You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardExpand all lines: report/Revision_manuscript.md
+1-1Lines changed: 1 addition & 1 deletion
Display the source diff
Display the rich diff
Original file line number
Diff line number
Diff line change
@@ -70,7 +70,7 @@ We also classified models by geographic target specificity. We assessed the tota
70
70
71
71
*Confounding factors associated with epidemiological context*
72
72
73
-
We considered aspects of the forecasting context that we believed could influence associations with forecast performance beyond the effects of interest. Among models, forecast performance typically declines with longer forecast horizons. We also considered the wider epidemiological setting of the forecast target. This included the trend of incidence in the target week for each location, which we categorised as “Stable”, “Decreasing”, or “Increasing”, based on the difference over a three-week moving average of incidence (with a change of \+/-5% as “Stable”; see Supplement). We also considered differing transmission characteristics with each Sars-Cov2 variant. We used publicly available sequence data to classify each target location-week according to the dominant circulating variant, creating a sequence of phases (see Supplement) (\#ref-variant-data). We considered extraneous variation at the country level, to account for, for example, effects of population size or different transmission probabilities with national policy.
73
+
We considered aspects of the forecasting context that we believed could influence associations with forecast performance beyond the effects of interest. Among models, forecast performance typically declines with longer forecast horizons. We also considered the wider epidemiological setting of the forecast target. This included the trend of incidence in the target week for each location, which we categorised as “Stable”, “Decreasing”, or “Increasing”, based on the difference over a three-week moving average of incidence (with a change of \+/-5% as “Stable”; see Supplement). We also considered differing transmission characteristics with each SARS-CoV-2 variant. We used publicly available genomic surveillance data from ECDC, UKHSA, and the Swiss Federal Office of Public Health to classify each target location-week according to the dominant circulating variant, assigning sequential variant phases (Alpha, Delta, Omicron BA.1, BA.2, BA.4/5, BQ/XBB) separately for each country based on when each variant first exceeded 50% of sequenced samples (see Supplement for details). We considered extraneous variation at the country level, to account for, for example, effects of population size or different transmission probabilities with national policy.
Copy file name to clipboardExpand all lines: report/supplement/Supplement.Rmd
+3-1Lines changed: 3 additions & 1 deletion
Original file line number
Diff line number
Diff line change
@@ -121,7 +121,7 @@ scores |>
121
121
122
122
```{r variant-phases, fig.cap="Variant phases identified by dominant variant in each location and week"}
123
123
# see: R/utils-variants.R
124
-
variant_phases <- classify_variant_phases()
124
+
variant_phases <- classify_variant_phases()
125
125
variant_phases |>
126
126
ggplot(aes(x = target_end_date, y = location, fill = VariantPhase)) +
127
127
geom_tile() +
@@ -131,6 +131,8 @@ variant_phases |>
131
131
theme(legend.position = "bottom")
132
132
```
133
133
134
+
Genomic surveillance data were obtained from three sources: ECDC (covering 30 European countries), UKHSA (Great Britain), and the Swiss Federal Office of Public Health (Switzerland). Variant lineages were mapped to six named phases in expected chronological order: Alpha, Delta, Omicron-BA.1, Omicron-BA.2, Omicron-BA.4/5, and Omicron-BQ/XBB. For each country, we identified the first week in which each named variant exceeded 50% of sequenced samples. We enforced chronological ordering by removing any out-of-sequence phases, then expanded phase assignments to all weeks by filling forward and backward from observed transition dates. This per-location approach accounts for the fact that variant dominance dates differed substantially across European countries. Where genomic surveillance data were too sparse to identify a transition (Hungary), we supplemented with epidemiological reports to set the Alpha-to-Delta transition date.
0 commit comments